export interface BlogPost {
  slug: string;
  title: string;
  excerpt: string;
  category: "Regulatory & Dossiers" | "Quality & GMP" | "Cold-Chain & Logistics" | "Market Expansion";
  date: string;
  readTime: string;
  author: {
    name: string;
    role: string;
    avatar: string;
  };
  coverImage: string;
  featured?: boolean;
  tags: string[];
  content: {
    summary: string;
    sections: {
      heading: string;
      paragraphs: string[];
      keyTakeaways?: string[];
    }[];
  };
}

export const BLOG_POSTS: BlogPost[] = [
  {
    slug: "ectd-dossier-submission-guide-africa-asia",
    title: "eCTD Dossier Submission Guide: Navigating Module 1–5 Compliance for Africa & Southeast Asia",
    excerpt: "A comprehensive breakdown of technical requirements for Electronic Common Technical Dossier (eCTD) formatting, bioequivalence study legalization, and fast-track MOH filings in emerging markets.",
    category: "Regulatory & Dossiers",
    date: "August 18, 2026",
    readTime: "7 min read",
    author: {
      name: "Dr. Rajesh Sharma",
      role: "Head of International Regulatory Affairs",
      avatar: "https://images.unsplash.com/photo-1537368910025-700350fe46c7?w=150&h=150&fit=crop&crop=faces",
    },
    coverImage: "https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?w=1200&h=650&fit=crop",
    featured: true,
    tags: ["eCTD", "Bioequivalence", "MOH Filing", "ACTD", "Africa Regulatory"],
    content: {
      summary: "Transitioning from paper-based submissions to eCTD has accelerated across global health ministries. Understanding specific regional variations in Module 1 administrative documents is the single most critical factor in avoiding regulatory review clock-stops.",
      sections: [
        {
          heading: "The Architecture of eCTD Modules 1 Through 5",
          paragraphs: [
            "The Electronic Common Technical Dossier (eCTD) format standardizes pharmaceutical product registration applications across international authorities. While Modules 2 through 5 represent the harmonized core (Quality Overall Summary, Chemical & Pharmaceutical Quality, Non-Clinical, and Clinical Study Reports), Module 1 remains strictly region-specific.",
            "In markets such as Nigeria (NAFDAC), Kenya (PPB), and Vietnam (DAV), local health ministries require specific legalized documents, including Certificate of Pharmaceutical Product (CPP / COPP) issued under the WHO certification scheme, notarized Letters of Authorization, and localized packaging artwork in dual languages.",
          ],
          keyTakeaways: [
            "Module 1 is authority-specific and requires notarized COPP legalizations.",
            "Module 2 requires a validated Quality Overall Summary (QOS) cross-referenced to analytical batch assays.",
            "Module 3 must reflect exact Active Pharmaceutical Ingredient (API) Drug Master File (DMF) specifications.",
          ],
        },
        {
          heading: "Common Pitfalls in Bioequivalence (BE) Documentation",
          paragraphs: [
            "Bioequivalence studies are mandatory for solid oral dosage forms to prove therapeutic interchangeability against international innovator reference drugs. Deficiencies in bioanalytical validation data, dissolution profile comparison in 3 different pH media (pH 1.2, 4.5, and 6.8), or f2 calculation methodologies frequently lead to registration delays.",
            "Zelnex prepares full in vitro dissolution profiles and GCP-audited BE clinical data ready for immediate submission to hospital procurement authorities and ministries of health.",
          ],
        },
        {
          heading: "Fast-Track Registration Strategies for Regional Blocs",
          paragraphs: [
            "Regional harmonization initiatives, such as the East African Community (EAC) Medicines Regulatory Harmonization (MRH) and the West African Health Organization (WAHO) protocols, allow pharmaceutical exporters to submit single joint assessment applications across multiple neighboring countries.",
            "By compiling harmonized dossiers that meet both EAC and ASEAN ACTD guidelines simultaneously, commercial market entry lead-time can be reduced by up to 60%.",
          ],
        },
      ],
    },
  },
  {
    slug: "zone-ivb-stability-testing-tropical-export",
    title: "Zone IVb Tropical Stability Testing: Formulating for 30°C / 75% RH Integrity",
    excerpt: "How real-time 36-month stability protocols, high-barrier tropical blister packaging, and moisture-scavenging desiccants guarantee shelf-life in hot and humid export markets.",
    category: "Quality & GMP",
    date: "August 12, 2026",
    readTime: "5 min read",
    author: {
      name: "Ananya Deshmukh",
      role: "VP of Quality Assurance & Formulations",
      avatar: "https://images.unsplash.com/photo-1573496359142-b8d87734a5a2?w=150&h=150&fit=crop&crop=faces",
    },
    coverImage: "https://images.unsplash.com/photo-1576086213369-97a306d36557?w=1200&h=650&fit=crop",
    tags: ["Zone IVb", "Stability Studies", "Alu-Alu Packaging", "Quality Assurance"],
    content: {
      summary: "Zone IVb represents the most demanding climatic condition defined by the WHO and ICH guidelines, requiring real-time testing at 30°C and 75% Relative Humidity for a minimum of 24 to 36 months.",
      sections: [
        {
          heading: "Understanding ICH Climatic Zones and Zone IVb Parameters",
          paragraphs: [
            "Pharmaceutical stability testing confirms how the quality of an active substance or finished formulation varies with time under the influence of environmental factors such as temperature, humidity, and light.",
            "For exports targeted at equatorial Africa, Southeast Asia, and Central America (Zone IVb: Hot and Higher Humidity), standard Zone II testing is insufficient for regulatory approval. Regulatory bodies in these territories mandate 30°C ± 2°C / 75% RH ± 5% RH long-term stability datasets.",
          ],
          keyTakeaways: [
            "Zone IVb testing mandates 30°C / 75% RH conditions across 6, 12, 18, 24, and 36-month intervals.",
            "Accelerated stability testing is conducted at 40°C / 75% RH for a 6-month period.",
            "Assay degradation limits must strictly adhere to pharmacopoeial specifications (USP/BP/EP).",
          ],
        },
        {
          heading: "High-Barrier Packaging Technology for Tropical Markets",
          paragraphs: [
            "Packaging is not merely presentation; it is an active protective barrier. For moisture-sensitive formulations such as clavulanate combinations and effervescent solids, Zelnex utilizes Cold-Form Aluminum (Alu-Alu) blisters with multi-layer laminate foils.",
            "This configuration provides a near-zero Water Vapor Transmission Rate (WVTR), preventing micro-porosity and active ingredient hydrolysis throughout international sea freight transit and extended shelf-life.",
          ],
        },
      ],
    },
  },
  {
    slug: "cold-chain-logistics-biologics-vaccines-transport",
    title: "Cold-Chain Logistics for Biologics & Vaccines: Mitigating Risk in High-Temperature Transit",
    excerpt: "Key strategies for temperature-controlled air cargo, multi-sensor data loggers, phase-change materials, and GDP-compliant customs clearance.",
    category: "Cold-Chain & Logistics",
    date: "July 29, 2026",
    readTime: "6 min read",
    author: {
      name: "Marcus Vance",
      role: "Director of Global Supply Chain",
      avatar: "https://images.unsplash.com/photo-1507003211169-0a1dd7228f2d?w=150&h=150&fit=crop&crop=faces",
    },
    coverImage: "https://images.unsplash.com/photo-1584515979956-d9f6e5d09982?w=1200&h=650&fit=crop",
    tags: ["Cold-Chain", "GDP Compliance", "Air Cargo", "Biologics", "Data Loggers"],
    content: {
      summary: "Maintaining an unbroken 2°C to 8°C cold-chain across multi-leg international flights and equatorial transit requires validated passive packaging, IoT live telemetry, and proactive green-lane customs brokerage.",
      sections: [
        {
          heading: "The 2°C – 8°C Cold-Chain Mandate",
          paragraphs: [
            "Biopharmaceuticals, lyophilized peptide vials, recombinant insulins, and vaccines require uninterrupted thermal stabilization. A single thermal excursion above 8°C or below 2°C (freezing denaturation) can compromise biological efficacy.",
            "Zelnex deploys Good Distribution Practice (GDP) validated passive shippers utilizing Phase Change Materials (PCM) engineered to maintain critical thermal windows for up to 120 hours without external power.",
          ],
          keyTakeaways: [
            "PCM containers maintain 2°C–8°C for 120+ hours during international flights.",
            "Real-time USB & Bluetooth data loggers record temperature, humidity, and tilt.",
            "Pre-cleared green-channel customs protocol eliminates airport tarmac dwell times.",
          ],
        },
        {
          heading: "Real-Time Telemetry and Corrective Action Protocols",
          paragraphs: [
            "Each cold-chain shipment is embedded with multi-point digital data loggers that record continuous temperature readings every 10 minutes. Upon arrival at destination port warehouses, the cryptographic audit trail is extracted and verified before final batch release.",
          ],
        },
      ],
    },
  },
  {
    slug: "who-gmp-sterile-cleanroom-classification-hvac",
    title: "WHO-GMP Sterile Manufacturing: Cleanroom Classification & HVAC Grade A Protocols",
    excerpt: "Inside advanced pharmaceutical production: laminar air flow hoods, differential pressure regimes, microbial environmental monitoring, and automated vial filling lines.",
    category: "Quality & GMP",
    date: "July 15, 2026",
    readTime: "8 min read",
    author: {
      name: "Dr. Rajesh Sharma",
      role: "Head of International Regulatory Affairs",
      avatar: "https://images.unsplash.com/photo-1537368910025-700350fe46c7?w=150&h=150&fit=crop&crop=faces",
    },
    coverImage: "https://images.unsplash.com/photo-1530497610245-94d3c16cda28?w=1200&h=650&fit=crop",
    tags: ["WHO-GMP", "Cleanrooms", "Sterile Injectables", "HVAC", "Audit Readiness"],
    content: {
      summary: "Adhering to revised WHO Good Manufacturing Practice standards for sterile medicinal products requires strict segregation of Grade A, B, C, and D cleanroom zones with continuous particle counting.",
      sections: [
        {
          heading: "Cleanroom Zoning Regimes and Differential Pressure Cascades",
          paragraphs: [
            "In sterile liquid and lyophilized vial production, critical operations such as filling and aseptic assembly must take place under Grade A laminar air flow workstations with unidirectional airflow velocities of 0.36 to 0.54 m/s.",
            "To prevent airborne cross-contamination, facilities maintain a 10 to 15 Pascal positive pressure cascade from cleanest zones outward toward gowning airlocks.",
          ],
          keyTakeaways: [
            "Grade A workstations feature continuous non-viable particle monitoring (<3,520 particles/m³ at ≥0.5 µm).",
            "HEPA filtration systems deliver 99.997% efficiency at 0.3-micron particulate size.",
            "Automated CIP/SIP (Clean-In-Place / Steam-In-Place) protocols sanitize all product contact lines.",
          ],
        },
        {
          heading: "Continuous Environmental Monitoring & Aseptic Process Simulation",
          paragraphs: [
            "Beyond physical HVAC controls, our manufacturing partners conduct semi-annual Media Fill trials (Aseptic Process Simulation) filling nutrient broth under routine production conditions to ensure microbial contamination rates below 0.1% at 95% confidence level.",
          ],
        },
      ],
    },
  },
  {
    slug: "navigating-nafdac-ppb-kenya-product-visas",
    title: "Navigating NAFDAC & PPB Kenya Product Visas: Fast-Track MOH Clearances",
    excerpt: "Practical insights on overcoming dossier queries, securing Clean Report of Inspection (CRIA), and accelerating commercial distribution across West and East Africa.",
    category: "Market Expansion",
    date: "June 30, 2026",
    readTime: "6 min read",
    author: {
      name: "Ananya Deshmukh",
      role: "VP of Quality Assurance & Formulations",
      avatar: "https://images.unsplash.com/photo-1573496359142-b8d87734a5a2?w=150&h=150&fit=crop&crop=faces",
    },
    coverImage: "https://images.unsplash.com/photo-1628348068343-c6a848d2b6dd?w=1200&h=650&fit=crop",
    tags: ["NAFDAC", "PPB Kenya", "MOH Visas", "Africa Export", "CRIA Clearance"],
    content: {
      summary: "Securing national pharmaceutical marketing authorizations in Africa requires close alignment with regional authority inspection schedules, pre-shipment CRIA documentation, and verified analytical testing.",
      sections: [
        {
          heading: "Nigeria: The NAFDAC Registration Pathway",
          paragraphs: [
            "NAFDAC registration involves a two-phase process: First, obtaining an Import Permit for registration samples, followed by physical laboratory assay verification at the Yaba or Oshodi testing facilities.",
            "Submitting pre-vetted certificates of analysis, complete stability data for Zone IVb, and pre-formatted bilingual package inserts accelerates the issuance of the 5-year commercial product visa.",
          ],
          keyTakeaways: [
            "NAFDAC sample submission requires validated reference standards and working assay protocols.",
            "Clean Report of Inspection and Analysis (CRIA) is mandatory for every commercial export container.",
            "Kenya Pharmacy & Poisons Board accepts harmonized EAC CTD format submissions.",
          ],
        },
        {
          heading: "Kenya and the East African Community (EAC) Portal",
          paragraphs: [
            "Kenya's Pharmacy and Poisons Board has digitized submissions via the automated PPB online portal. Utilizing our pre-compiled CTD dossiers with complete batch records and WHO-GMP audit reports ensures seamless review without administrative queries.",
          ],
        },
      ],
    },
  },
];
